FMX FMX
Company Profile ↓Company Overview
FMX (FMX) is a publicly traded company listed on with a market capitalization of $427.79B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 12.1% CAGR over the past five years.
Trades at an undemanding P/E of 2.5.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $840.95B (+7.6% YoY); net profit $19.43B.
- Trailing 12 Months Year-on-year growth — revenue +7.6%, earnings -27.3%.
- 5-Year Trend Long-term compounding — revenue CAGR 12.1%, profit CAGR -6.7%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 12.10% |
| 1 Year: | 7.60% |
Compounded Profit Growth
| 5 Years: | -6.68% |
| 1 Year: | -27.32% |
Stock Price Performance
| 1 Year: | +45.06% |
| 6 Months: | +18.13% |
| 3 Months: | +3.97% |
| 1 Month: | -2.63% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMAAbove
- RSI (14)46.13 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 12.1% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Earnings shrank at -6.7% CAGR over 5 years.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 211.36B | 214.64B | 220.10B | 207.78B | 231.00B |
| Cost of Revenue | - | 125.44B | 128.93B | 128.68B | 123.69B | 138.39B |
| Gross Profit | - | 85.92B | 85.71B | 91.43B | 84.09B | 92.61B |
| Operating Expenses | - | 68.09B | 67.58B | 68.72B | 69.78B | 73.50B |
| Operating Income | - | 17.83B | 18.12B | 22.71B | 14.31B | 19.11B |
| EBITDA | - | 16.14B | 18.39B | 20.32B | 26.87B | 19.62B |
| Interest Expense | - | 5.30B | 5.47B | 2.51B | 5.47B | 5.53B |
| Pretax Income | - | 10.84B | 12.92B | 17.81B | 21.40B | 14.09B |
| Tax Provision | - | 4.34B | 3.79B | 7.00B | 3.66B | 4.91B |
| Net Income | - | 2.71B | 2.42B | 8.51B | 14.83B | 5.54B |
| Diluted EPS | - | 7.83 | 6.99 | 24.84 | 43.20 | 16.25 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 597.01B | 702.69B | 781.59B | 840.95B |
| Cost of Revenue | - | 355.49B | 423.19B | 460.07B | 499.38B |
| Gross Profit | - | 241.52B | 279.51B | 321.51B | 341.58B |
| Operating Expenses | - | 177.89B | 222.15B | 251.11B | 269.42B |
| Operating Income | - | 63.63B | 57.36B | 70.41B | 72.16B |
| EBITDA | - | 91.49B | 109.03B | 123.43B | 115.39B |
| Interest Expense | - | 14.47B | 17.19B | 17.58B | 18.42B |
| Pretax Income | - | 46.50B | 57.82B | 66.55B | 52.84B |
| Tax Provision | - | 13.28B | 12.97B | 25.43B | 19.86B |
| Net Income | - | 23.91B | 65.69B | 26.73B | 19.43B |
| Diluted EPS | - | 69.19 | 185.54 | 112.11 | 49.50 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 798.82B | 805.86B | 851.54B | 795.88B |
| Current Assets | - | 226.45B | 356.16B | 342.31B | 283.12B |
| Cash & Equivalents | - | 83.44B | 165.11B | 139.83B | 107.98B |
| Inventory | - | 62.22B | 58.22B | 67.46B | 69.45B |
| Receivables | - | 40.11B | 34.42B | 38.46B | 43.51B |
| Total Liabilities | - | 461.01B | 427.49B | 470.40B | 466.52B |
| Current Liabilities | - | 176.92B | 182.38B | 202.93B | 210.01B |
| Long Term Debt | - | 173.40B | 128.37B | 141.48B | 126.99B |
| Total Debt | - | 285.06B | 232.90B | 256.30B | 257.56B |
| Total Equity | - | 262.60B | 303.86B | 297.50B | 244.98B |
| Shares Outstanding | - | 3.58B | 3.58B | 3.58B | 3.44B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 72.58B | 49.68B | 71.51B | 71.08B |
| Investing Cash Flow | - | -46.43B | 132.29B | -33.12B | -2.06B |
| Financing Cash Flow | - | -35.90B | -92.55B | -84.05B | -92.00B |
| Capital Expenditure | - | -31.47B | -38.12B | -47.31B | -42.05B |
| Free Cash Flow | - | 41.10B | 11.56B | 24.20B | 29.03B |
| Net Change in Cash | - | -9.75B | 89.42B | -45.66B | -22.98B |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 40.5% | 39.8% | 41.1% | 40.6% |
| Operating Margin % | - | 10.7% | 8.2% | 9.0% | 8.6% |
| Net Margin % | - | 4.0% | 9.3% | 3.4% | 2.3% |
| ROE % | - | 9.1% | 21.6% | 9.0% | 7.9% |
| ROCE % | - | 10.2% | 9.2% | 10.9% | 12.3% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for FMX
Can FEMSA's Q2 Momentum Offset Margin Pressure Across Its Portfolio?
FEMSA's Q2 beat and core-business growth drove momentum, but weaker international profits and margin pressure clouded the gains.
Is FEMSA Stock Worth Buying Now as Growth Meets a Premium Valuation?
FEMSA's retail and digital growth strengthens its long-term case, but a premium valuation and weak international margins suggest patience.
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Apple, CoreWeave, eBay, Exxon Mobil, Intuit, Nebius Group, Palantir Technologies, SK hynix, and More
Wall Street wasted no time Monday, sending the Nasdaq surging past 25,900 while analysts took aim at some of the market's biggest names with fresh upgrades, downgrades, and new coverage that could reshape how investors approach the week ahe…
AB InBev Misses Q2 Earnings & Revenues Estimates, Reaffirms 2026 View
BUD's Q2 sales and earnings miss estimates, but organic growth, premium brands, digital gains and stronger cash flow support its 2026 outlook.
FMX Q2 Earnings Call Highlights OXXO Strategy Shift
FMX advances its OXXO strategy with stronger traffic, digital expansion and growth initiatives as consumer-focused changes gain traction.
FEMSA Q2 Earnings & Revenues Beat on OXXO Mexico & Coca-Cola FEMSA
FMX's Q2 earnings and revenues beat estimates as OXXO Mexico sales climb and Coca-Cola FEMSA delivers margin expansion and profit growth.
FMX — Frequently Asked Questions
What is the current share price of FMX?
As of 2026-08-05 17:25 PDT, FMX trades at $124.37 on NASDAQ/NYSE. Its 52-week range is $81.24 to $132.15.
What is the market capitalisation of FMX?
FMX has a market capitalisation of $427.79B on NASDAQ/NYSE.
What is the P/E ratio of FMX?
FMX trades at a trailing price-to-earnings (P/E) ratio of 2.51. Its price-to-book (P/B) ratio is 1.75.
What is the return on equity (ROE) of FMX?
FMX has a return on equity (ROE) of 7.93%. Its return on capital employed (ROCE) is 12.32%.
Is FMX a good stock to buy?
This page provides a data-driven analysis of FMX, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.